Home/Filings/4/0000899243-23-000826
4//SEC Filing

Badawi Paul 4

Accession 0000899243-23-000826

CIK 0001531177other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 6:30 AM ET

Size

7.5 KB

Accession

0000899243-23-000826

Insider Transaction Report

Form 4
Period: 2023-01-01
Badawi Paul
DirectorPresident and CEO10% Owner
Transactions
  • Award

    Common Stock

    2023-01-01+87,8005,286,732 total
  • Tax Payment

    Common Stock

    2023-01-04$12.21/sh8,251$100,7455,278,481 total
Footnotes (4)
  • [F1]Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person on February 9, 2022 under the Issuer's 2021 Incentive Award Plan (such grant, the "2022 RSU Grant"), as reported in Table II on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on February 11, 2022. Of the RSUs awarded to the Reporting Person under the 2022 RSU Grant, 25% vested on January 1, 2023, and an additional 25% vest on each of January 1, 2024, 2025, and 2026. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The RSUs have no expiration date.
  • [F2]Includes 21,950 shares of Common Stock issued in connection with the January 1, 2023 vesting of the 2022 RSU Grant.
  • [F3]Reflects shares of Common Stock withheld by the Issuer to cover the Reporting Person's tax liability in connection with the vesting of RSUs.
  • [F4]Reflects the closing sale price of the Issuer's Common Stock as reported on The Nasdaq Global Select Market on December 30, 2022.

Issuer

Sight Sciences, Inc.

CIK 0001531177

Entity typeother

Related Parties

1
  • filerCIK 0001870865

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:30 AM ET
Size
7.5 KB